CBMR's Zach Gerhart-Hines is awarded the first Flemming Quaade Prize for Outstanding Obesity Research for his pioneering discoveries on how fat tissue influences insulin sensitivity, energy expenditure, and appetite control.

Read more: cbmr.ku.dk/news/2025/za...

#obesity #metabolism

Could the season you were conceived determine your lifelong health?

@camillascheele.bsky.social & Taylah Gaynor ask why cold temperatures during the pre-conception period are associated with higher BAT density and activity and point to a possible epigenetic reprogramming of the father's sperm.

1/2

@cellpress.bsky.social Review 🚨 ‘Brain control of energy homeostasis: Implications for anti-obesity pharmacotherapy’

Lead author: @johansenvbi.bsky.social
Senior author: @clemmensenc.bsky.social

Read it here: www.cell.com/cell/fulltex...

Kickstart your research career in Copenhagen with a PhD or Postdoctoral fellowship at CBMR!

Four PhD and four Postdoc positions are currently available:

cbmr.ku.dk/join-us/fell...

#phdposition #postdocposition

🔎 𝐃𝐞𝐜𝐢𝐩𝐡𝐞𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐆𝐈𝐏 𝐩𝐚𝐫𝐚𝐝𝐨𝐱

Why does activating the GIP receptor contribute to weight-loss, given the evidence that blocking the receptor ought to be more effective?

Prof. Jens Juul Holst outlines the evidence in Diabetes 👇

diabetesjournals.org/diabetes/art...

#GIP #GLP1 #biotech #obesity

CBMR spinout Ousia Pharma has secured significant seed funding from the Boston-based venture fund Omega Funds to support the preclinical and clinical development of a once-weekly, dual-incretin-NMDA receptor antagonist conjugate.

cbmr.ku.dk/news/2025/cb...

@clemmensenc.bsky.social

#biotech #glp1

New research in @nature.com Medicine by
@martaguasch1.bsky.social investigates the relationship between what we eat in midlife and the chances of reaching old age with good physical, cognitive, and mental health and without chronic diseases.

cbmr.ku.dk/news/2025/ea...

And that’s a wrap! 🥂

A huge thanks to everyone who joined us at Metabolism Day 2025 - whether you travelled from abroad, tuned in online, or nipped across the city. The talks were inspiring, the questions were thought provoking and the poster presentations exciting. 🚀

We hope to see you next year!

Full house! 🚀 Executive Director Professor @juleenrzierath.bsky.social opens Metabolism Day with an introduction to the center for our many external attendees in the audience and livestream. #MD25

𝐋𝐄𝐀𝐏2: 𝐀 𝐧𝐞𝐰 𝐡𝐨𝐫𝐦𝐨𝐧𝐞 𝐰𝐢𝐭𝐡 𝐛𝐢𝐠 𝐢𝐦𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐟𝐨𝐫 𝐦𝐞𝐭𝐚𝐛𝐨𝐥𝐢𝐬𝐦?

Research published today in @cp-cellrepmed.bsky.social shows that #insulin and #glucagon play a crucial role in regulating levels of LEAP2 - a newly discovered hormone with promise for treating cardiometabolic disease.

1/

🧠💊 𝐁𝐫𝐚𝐢𝐧-𝐭𝐚𝐫𝐠𝐞𝐭𝐢𝐧𝐠 𝐚𝐧𝐭𝐢-𝐨𝐛𝐞𝐬𝐢𝐭𝐲 𝐦𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬

In this @cp-cellmetabolism.bsky.social SnapShot, the @clemmensenc.bsky.social Group provide an overview of the current and emerging peptide-based drugs, which offer great potential to combat cardiometabolic diseases.

www.sciencedirect.com/science/arti...

𝐂𝐮𝐫𝐢𝐨𝐮𝐬 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐞 𝐬𝐜𝐢𝐞𝐧𝐜𝐞 𝐛𝐞𝐡𝐢𝐧𝐝 𝐜𝐫𝐚𝐯𝐢𝐧𝐠𝐬 𝐝𝐮𝐫𝐢𝐧𝐠 𝐩𝐫𝐞𝐠𝐧𝐚𝐧𝐜𝐲?

If you live in Copenhagen, you can book PhD student Erica Eberl for a lecture on the research surrounding pregnancy cravings and why we should pay attention to them!

To book Erica, follow the link below! 👇

forsk.dk/indbakke/why...

🍿 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐧𝐨𝐰 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐌𝐞𝐭𝐚𝐛𝐨𝐥𝐢𝐬𝐦 𝐃𝐚𝐲 2025 𝐥𝐢𝐯𝐞𝐬𝐭𝐫𝐞𝐚𝐦 𝐨𝐧 𝐌𝐚𝐫𝐜𝐡 11!

👩‍🔬 The conference brings together researchers to discuss the latest science in cardiometabolic diseases and energy control.

Learn more about the speakers here: bit.ly/41FciTx

Register for the live stream here: bit.ly/MD25_virtual

💪 𝐑𝐞𝐭𝐡𝐢𝐧𝐤𝐢𝐧𝐠 𝐌𝐮𝐬𝐜𝐥𝐞: 𝐍𝐞𝐰 𝐬𝐭𝐮𝐝𝐲 𝐜𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 𝐨𝐥𝐝 𝐜𝐥𝐚𝐬𝐬𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬

🔬 Our current approach to dividing muscle fibers into separate types may need to be revised following new research in Nature Communications by a team of scientists, including AssocProf Atul Deshmukh.

👇

www.nature.com/articles/s41...